Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma
Zhi-Hang Zhou(Shanghai Jiao Tong University), Lai‐ping Zhong(National Clinical Research Center for Digestive Diseases)
Cited by 56
Related Papers
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
|Nature Communications|2022|119
Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
|Journal of Experimental & Clinical Cancer Research|2017|35